Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

bioAffinity Technologies (BIAF) Equity Ratio (2022 - 2025)

Historic Equity Ratio for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to 0.77.

  • bioAffinity Technologies' Equity Ratio rose 6185.62% to 0.77 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.77, marking a year-over-year increase of 6185.62%. This contributed to the annual value of 0.4 for FY2024, which is 3235.6% down from last year.
  • Latest data reveals that bioAffinity Technologies reported Equity Ratio of 0.77 as of Q3 2025, which was up 6185.62% from 0.45 recorded in Q2 2025.
  • Over the past 5 years, bioAffinity Technologies' Equity Ratio peaked at 0.92 during Q1 2023, and registered a low of 0.45 during Q2 2025.
  • For the 4-year period, bioAffinity Technologies' Equity Ratio averaged around 0.58, with its median value being 0.65 (2024).
  • Within the past 5 years, the most significant YoY rise in bioAffinity Technologies' Equity Ratio was 6185.62% (2025), while the steepest drop was 18717.37% (2025).
  • Quarter analysis of 4 years shows bioAffinity Technologies' Equity Ratio stood at 0.91 in 2022, then tumbled by 34.86% to 0.59 in 2023, then plummeted by 32.36% to 0.4 in 2024, then skyrocketed by 93.0% to 0.77 in 2025.
  • Its Equity Ratio was 0.77 in Q3 2025, compared to 0.45 in Q2 2025 and 0.26 in Q1 2025.